Literature DB >> 8530553

Cholinergic projection from the basal forebrain and cerebral glucose metabolism in rats: a dynamic PET study.

Y Ouchi1, H Fukuyama, M Ogawa, H Yamauchi, J Kimura, Y Magata, Y Yonekura, J Konishi.   

Abstract

To investigate the influence of cholinergic projections from the basal forebrain on cerebral cortex metabolism, we evaluated the cerebral metabolic rate of glucose (CMRGlu) after selective inhibition of cholinergic neurons in the rat basal forebrain using the pyruvate dehydrogenase complex inhibitor 3-bromopyruvic acid (BPA), and compared the results with those obtained after lesioning the basal forebrain with ibotenic acid, as well as with those from a sham-operated control group. CMRGlu was measured using positron emission tomography (PET) with [18F]-2-fluoro-2-deoxy-D-glucose (FDG). Three days after surgery, CMRGlu and k3 (phosphorylation of FDG) were reduced similarly in the frontal cortex on the BPA-injected side and in the ibotenic acid-treated group, whereas K1 (transport rate of FDG from the plasma to brain) showed no marked changes. At 3 weeks postoperatively, the CMRGlu and k3 of the frontal cortex in both groups recovered to levels similar to those of the sham-operated group. The main difference between the BPA and ibotenic acid groups was that CMRGlu showed mild reduction on the side contralateral to the operation in the former, while such reduction was confined to the ipsilateral hemisphere in the latter. The present results indicate that the cholinergic system in the basal forebrain regulates cerebral cortex glucose metabolism through direct excitation of cortical neurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8530553     DOI: 10.1097/00004647-199601000-00004

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  7 in total

Review 1.  Cholinergic modulation of cognition: insights from human pharmacological functional neuroimaging.

Authors:  Paul Bentley; Jon Driver; Raymond J Dolan
Journal:  Prog Neurobiol       Date:  2011-06-17       Impact factor: 11.685

2.  Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

Authors:  H Tsukada; J Kreuter; C E Maggos; E M Unterwald; T Kakiuchi; S Nishiyama; M Futatsubashi; M J Kreek
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function.

Authors:  Philipp T Meyer; Valentina Circiumaru; Christopher A Cardi; Daniel H Thomas; Harshali Bal; Paul D Acton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-13       Impact factor: 9.236

4.  Noninvasive quantification of cerebral metabolic rate for glucose in rats using (18)F-FDG PET and standard input function.

Authors:  Yuki Hori; Naoki Ihara; Noboru Teramoto; Masako Kunimi; Manabu Honda; Koichi Kato; Takashi Hanakawa
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

5.  The effects of perinatal bisphenol A exposure on thyroid hormone homeostasis and glucose metabolism in the prefrontal cortex and hippocampus of rats.

Authors:  Xiaobin Xu; Shijun Fan; Yuanqiao Guo; Ruei Tan; Junyu Zhang; Wenhua Zhang; Bing-Xing Pan; Nobumasa Kato
Journal:  Brain Behav       Date:  2019-02-13       Impact factor: 2.708

6.  Comparison of different quantification methods for 18F-fluorodeoxyglucose-positron emission tomography studies in rat brains.

Authors:  Silvana Prando; Camila de Godoi Carneiro; Cecil Chow Robilotta; Marcelo Tatit Sapienza
Journal:  Clinics (Sao Paulo)       Date:  2019-09-26       Impact factor: 2.365

7.  Basal Forebrain Cholinergic Deficits Reduce Glucose Metabolism and Function of Cholinergic and GABAergic Systems in the Cingulate Cortex.

Authors:  Da Un Jeong; Jin Hwan Oh; Ji Eun Lee; Jihyeon Lee; Zang Hee Cho; Jin Woo Chang; Won Seok Chang
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.